Elagolix treatment in women with heavy menstrual bleeding associated with uterine fibroid: a systematic review and meta-analysis

BACKGROUND: Elagolix is effective and safe for treating menorrhagia in women with uterine fibroid. However, it is reported to be associated with hypoestrogenism that can be alleviated by adding estradiol/norethindrone acetate. This systematic review and meta-analysis aimed to determine the effective...

Descripción completa

Detalles Bibliográficos
Autores principales: Muhammad, Juliawati, Yusof, Yusnita, Ahmad, Imran, Norhayati, Mohd Noor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761302/
https://www.ncbi.nlm.nih.gov/pubmed/35033041
http://dx.doi.org/10.1186/s12905-022-01596-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761302/
https://www.ncbi.nlm.nih.gov/pubmed/35033041
http://dx.doi.org/10.1186/s12905-022-01596-2

Ejemplares similares